Literature DB >> 8226684

Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon.

K Poole1, K Krebes, C McNally, S Neshat.   

Abstract

An outer membrane protein of 50 kDa (OprK) was overproduced in a siderophore-deficient mutant of Pseudomonas aeruginosa capable of growth on iron-deficient minimal medium containing 2,2'-dipyridyl (0.5 mM). The expression of OprK in the mutant (strain K385) was associated with enhanced resistance to a number of antimicrobial agents, including ciprofloxacin, nalidixic acid, tetracycline, chloramphenicol, and streptonigrin. OprK was inducible in the parent strain by growth under severe iron limitation, as provided, for example, by the addition of dipyridyl or ZnSO4 to the growth medium. The gene encoding OprK (previously identified as ORFC) forms part of an operon composed of three genes (ORFABC) implicated in the secretion of the siderophore pyoverdine. Mutants defective in ORFA, ORFB, or ORFC exhibited enhanced susceptibility to tetracycline, chloramphenicol, ciprofloxacin, streptonigrin, and dipyridyl, consistent with a role for the ORFABC operon in multiple antibiotic resistance in P. aeruginosa. Sequence analysis of ORFC (oprK) revealed that its product is homologous to a class of outer membrane proteins involved in export. Similarly, the products of ORFA and ORFB exhibit homology to previously described bacterial export proteins located in the cytoplasmic membrane. These data suggest that ORFA-ORFB-oprK (ORFC)-dependent drug efflux contributes to multiple antibiotic resistance in P. aeruginosa. We propose, therefore, the designation mexAB (multiple efflux) for ORFAB.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8226684      PMCID: PMC206881          DOI: 10.1128/jb.175.22.7363-7372.1993

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  58 in total

Review 1.  Biogenesis of lipoproteins in bacteria.

Authors:  H C Wu; M Tokunaga
Journal:  Curr Top Microbiol Immunol       Date:  1986       Impact factor: 4.291

2.  Quinolone/ureidopenicillin cross-resistance.

Authors:  L J Piddock; W J Wijnands; R Wise
Journal:  Lancet       Date:  1987-10-17       Impact factor: 79.321

3.  Iron enhances the bactericidal action of streptonigrin.

Authors:  J R White; H N Yeowell
Journal:  Biochem Biophys Res Commun       Date:  1982-05-31       Impact factor: 3.575

4.  Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.

Authors:  K Hirai; H Aoyama; S Suzue; T Irikura; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

5.  Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

Authors:  C C Sanders; W E Sanders; R V Goering; V Werner
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

6.  Molecular cloning and characterization of the fusaric acid-resistance gene from Pseudomonas cepacia.

Authors:  R Utsumi; T Yagi; S Katayama; K Katsuragi; K Tachibana; H Toyoda; S Ouchi; K Obata; Y Shibano; M Noda
Journal:  Agric Biol Chem       Date:  1991-07

7.  Characterization of the inducible nickel and cobalt resistance determinant cnr from pMOL28 of Alcaligenes eutrophus CH34.

Authors:  H Liesegang; K Lemke; R A Siddiqui; H G Schlegel
Journal:  J Bacteriol       Date:  1993-02       Impact factor: 3.490

8.  Cell cycle-independent lysis of Escherichia coli by cefsulodin, an inhibitor of penicillin-binding proteins 1a and 1b.

Authors:  G H Jacoby; K D Young
Journal:  J Bacteriol       Date:  1991-01       Impact factor: 3.490

9.  Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation.

Authors:  D C Hooper; J S Wolfson; K S Souza; E Y Ng; G L McHugh; M N Swartz
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

10.  Siderophore presence in sputa of cystic fibrosis patients.

Authors:  B Haas; J Kraut; J Marks; S C Zanker; D Castignetti
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

View more
  249 in total

1.  Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa.

Authors:  T Köhler; S F Epp; L K Curty; J C Pechère
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

2.  Hypersusceptibility of the Pseudomonas aeruginosa nfxB mutant to beta-lactams due to reduced expression of the ampC beta-lactamase.

Authors:  N Masuda; E Sakagawa; S Ohya; N Gotoh; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

3.  Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece.

Authors:  A Tsakris; S Pournaras; N Woodford; M F Palepou; G S Babini; J Douboyas; D M Livermore
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

4.  Insertion mutagenesis and membrane topology model of the Pseudomonas aeruginosa outer membrane protein OprM.

Authors:  K K Wong; R E Hancock
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

5.  Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance.

Authors:  A Lee; W Mao; M S Warren; A Mistry; K Hoshino; R Okumura; H Ishida; O Lomovskaya
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

6.  Influence of mutations in the mexR repressor gene on expression of the MexA-MexB-oprM multidrug efflux system of Pseudomonas aeruginosa.

Authors:  R Srikumar; C J Paul; K Poole
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

7.  Resistance to beta-lactam antibiotics in Pseudomonas aeruginosa due to interplay between the MexAB-OprM efflux pump and beta-lactamase.

Authors:  T Nakae; A Nakajima; T Ono; K Saito; H Yoneyama
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

8.  The Red Menace: Emerging Issues in Antimicrobial Resistance in Gram-Negative Bacilli.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

Review 9.  Molecular properties of bacterial multidrug transporters.

Authors:  M Putman; H W van Veen; W N Konings
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

Review 10.  Bacterial quorum sensing in pathogenic relationships.

Authors:  T R de Kievit; B H Iglewski
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.